Advertisement

Asthma News: Breaking Asthma News, Comments and Articles. - Page: 3

10:47 EDT 22nd May 2013 | BioPortfolio

Asthma News - Page: 3 RSSTwitter

Read the latest Asthma News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Asthma.

Search or Follow Our Asthma - Page: 3 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Asthma - Page: 3 News.
You can also follow our Asthma - Page: 3 news stories on Twitter: @asthma_bio

Showing "asthma" News Articles 51 to 75 of 2,100+

Monday 20th May 2013

Purified components of ginger help asthma patients breathe more easily

Gourmands and foodies everywhere have long recognized ginger as a great way to add a little peppery zing to both sweet and savory dishes; now, a study from researchers at Columbia University shows purified components of the spicy root also may have p...

Sunday 19th May 2013

Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference

RIDGEFIELD, Conn., May 17, 2013 /PRNewswire/ -- Boehringer Ingelheim will contribute to advancing the scientific discussion in respiratory disease at the American Thoracic Society International Conference (ATS 2013) in Philadelphia, PA, May 17 – 22, with 17 presentations. Data will highlight research conducted with a product approved for the treatment of chronic obstructive pulmonary di...

Transition to Propellant-Free Combivent® Respimat® (ipratropium bromide and albuterol) Inhalation Spray Nears Completion

RIDGEFIELD, Conn., May 17, 2013 /PRNewswire/ -- As part of the company's commitment to chronic obstructive pulmonary disease (COPD) patients, Boehringer Ingelheim Pharmaceuticals, Inc., a leader in respiratory health, is updating healthcare professionals (HCPs) and patients that the transition to COMBIVENT® RESPIMAT® (ipratropium bromide and albuterol) Inhalation Spray for the maintenanc...

Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy

ORLANDO, Fla., May 19, 2013 /PRNewswire/ -- The non-surgical Stretta® procedure employing low power and low temperature radiofrequency (RF) energy is effective in control of gastroesophageal reflux disease (GERD), and eliminates or reduces the need for medication 10 years post-procedure, according to an independent, prospective long-term assessment presented today at the Digestive Diseas...

Simulator Helps Asthma Patients Breathe Easier (CME/CE)

PHILADELPHIA (MedPage Today) -- A 5-minute test with a simulator helps asthma patients learn how to correctly use their inhalers, nearly doubling the chance of being in therapeutic range at the next visit, researchers reported here.

Ginger compounds may be effective in treating asthma symptoms, study suggests

Gourmands and foodies everywhere have long recognized ginger as a great way to add a little peppery zing to both sweet and savory dishes; now, a study shows purified components of the spicy root also may have properties that help asthma patients brea...

Potential new risk for sleep apnea identified: Asthma

Researchers have identified a potential new risk factor for obstructive sleep apnea: asthma.

Saturday 18th May 2013

Ginger compounds may be effective in treating asthma symptoms

(American Thoracic Society) Gourmands and foodies everywhere have long recognized ginger as a great way to add a little peppery zing to both sweet and savory dishes; now, a study from researchers at Columbia University shows purified components of th...

Researchers identify a potential new risk for sleep apnea: Asthma

(American Thoracic Society) Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma.

Friday 17th May 2013

Vectura establishes strategic partnership for new respiratory business in China

Vectura Group plc has established Tianjin Kinnovata Pharmaceutical Company Limited (Kinnovata) in China with two partners, Tianjin KingYork Group Company Limited (KingYork), a Chinese pharmaceutical company and specialist manufacturer of corticostero...

Thursday 16th May 2013

A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing

SINGAPORE and ZURICH, May 17, 2013 /PRNewswire/ -- Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their H1N1 influenza vaccine candidate based on Cytos' proprietary bacteriophage Qbeta virus-like particle (VLP) technology. In this first Phase...

Suffering from Allergies or Asthma Attacks? Pests and Rodents Could Be the Triggers

It’s May. Unfortunately, along with our love of spring can come a resurgence of allergies and asthma attacks. Just don’t blame it all on the pollen. It could be the pests. May is National Asthma and Allergy Awareness Month, and with it comes a little-known fact that pests and rodents can also emit allergens—miniscule particles that can produce mild t...

Sunovion to Present Three Posters on Results of One-year Large Simple Safety Study for BROVANA® (arformoterol tartrate) Inhalation Solution at 2013 ATS International Conference

Additional Data Presented by Sunovion Demonstrate Commitment to Nebulized COPD Treatments Sunovion Pharmaceuticals Inc. (Sunovion) announced today that the company will present six posters at the 2013 American Thoracic Society (ATS) International Conference, three of which pertain to a recently completed, one-year, placebo-controlled, large simple safe...

Nuvo Research wins US patent for WF10 drug candidate

Canada-based pharmaceutical company Nuvo Research has received US Patent relating to compositions and methods of using WF10 and new derivative formulations for the treatment of allergic asthma, allergic rhinitis and atopic dermatitis.

Asmacure to Present Four Posters on Novel Pulmonary Development Compound ASM-024 at American Thoracic Society 2013 International Conference

QUEBEC CITY, May 16, 2013 /PRNewswire/ -- Asmacure Ltee, a clinical-stage biopharmaceutical company focused on the development of novel, proprietary compounds that target cholinergic receptors for the treatment of pulmonary diseases, today announced that the company will present four posters at the 2013 American Thoracic Society (ATS) International Conference, taking place May 17-22 in Philad...

Football Legend Jerome Bettis & Sanofi US Tackle Anaphylaxis During National Asthma and Allergy Awareness Month

BRIDGEWATER, N.J., May 16, 2013 /PRNewswire/ -- Professional football icon Jerome Bettis and Sanofi US, the makers of Auvi-Q™ (epinephrine injection, USP), have teamed up to raise awareness about severe allergic reactions (anaphylaxis) and introduce The Severe Allergy & Anaphylaxis Playbook – a collection of tips to help educate people living with severe allergies, and their friend...

CascadeBreath LLC Offers $100 Off All Asthma Relief Programs

To celebrate Asthma Awareness Month, CascadeBreath of Bend, OR is offering $100 off all Asthma Relief Programs through June 14. It's time to control your asthma and CascadeBreath is prepared to guarantee it. Bend, Oregon (PRWEB) May 16, 2013 May is Asthma Awareness Month and CascadeBreath of Bend, OR is pleased to support the Global Initiative for Asthma's initiative “It's time to...

Wednesday 15th May 2013

Community Catalyst study shows dental therapists expand access to people in remote areas

Lack of access to dental care in the United States has reached epic proportions. Dental disease is the number one chronic illness affecting children - more common than asthma. The Institute of Medicine clearly states that the current dental delivery...

DBV Technologies and Stallergenes Enter Into Partnership for the Development of Innovative Treatment of Respiratory Allergies

ANTONY, FRANCE and BAGNEUX, FRANCE -- (Marketwired) -- 05/16/13 -- DBV Technologies (EURONEXT PARIS: DBV) (ISIN: FR0010417345), creator of Viaskin®, a new standard in the treatment of allergies, and Stallergenes S.A. (Euronext Paris CAC small), worldwide leader in allergen immunotherapy, announced today that they have entered into a strategic research partnership. This partnership combines Stal...

Utah Researchers to Study Asthma Monitoring in Children

Newswise - (SALT LAKE CITY) -The Patient-Centered Outcomes Research Institute (PCORI) has approved a $1.9 million research award to the University of Utah to study asthma in children and how better monitoring of the disease could improve health. Flory Nkoy, MD, MS, MPH, will lead the research project at the University of Utah. Nkoy serves as Associate Research Professor at the University of Ut...

Airway inflammation and oxidative potential of air pollutant particles in a pediatric asthma panel

No Exam Life Insurance Quotes can be Compared at Online Insurance Marketplace by People Working in Dangerous Environments

Online Insurance Marketplace (http://www.onlineinsurancemarketplace.com), announces new blog, “Dangerous jobs for you lungs.” (PRWEB) May 15, 2013 Online Insurance Marketplace has released a blog that gives details about dangerous working environments for people’s lungs! The blog mentions some of the most dangerous jobs for people’s lungs. For example, the smoke inhaled by the firefighter...

Pulmonary and Critical Care Specialists of Northern Virginia Celebrates National Women's Health Week: May 12th - 18th, 2013

Understanding the impact asthma has on women and why it affects them more than men. Fairfax, VA (PRWEB) May 15, 2013 Asthma is a disease that affects people's lungs. Asthma is a disorder that causes the airways of the lungs to swell and narrow, leading to wheezing, shortness of breath, chest tightness, and coughing. When it comes to women and asthma, the ability to breathe can be affected by...

Community Catalyst Responds To ADA Oral Health Campaign

BOSTON, May 15, 2013 /PRNewswire-USNewswire/ -- "Lack of access to dental care in the United States has reached epic proportions. Dental disease is the number one chronic illness affecting children – more common than asthma. The Institute of Medicine clearly states that the current dental delivery system doesn't work for a third of the people in the U.S. (Photo: http://photos.prnewswi...

PCORI Opens Second Year of Research Funding with $81 Million in New Round of Announcements

WASHINGTON, May 15, 2013 /PRNewswire-USNewswire/ -- The Patient-Centered Outcomes Research Institute (PCORI) today opened its second year of funding of patient-centered comparative clinical effectiveness research (CER), revising its broad funding announcements to clarify key review criteria and application definitions. PCORI plans to award up to $81 million in this newly announced round of P...


Search BioPortfolio:
Advertisement

News Quicklinks

Advertisement